Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Consolidation with Autologous Hematopoietic Cell Transplant in First Remission Improves Overall Survival in Younger Patients with Mantle Cell Lymphoma in the Rituximab Era

James Nathan Gerson, MD, Stefan Klaus Barta, MDMRCP,MS, Diego Villa, Alina S Gerrie, MD, Shaoying Li, MD, Jeffrey Medeiros, MD, Michael Wang, MD, Brian T. Hill, MD PhD, Yazeed Sawalha, MD, Francisco J. Hernandez-Ilizaliturri, MD, Shalin Kothari, MD, Julie M Vose, MD, Timothy S. Fenske, MD, Swapna Narayana Rao, MD, Kami J. Maddocks, MD, David A Bond, MD, Frederick Lansigan, MD, Timothy Burns, MD, Alexandra M Donovan, MD, Amitkumar Mehta, MD, Nishitha Reddy, MD MSCI, MBBS, Daniel J. Landsburg, MD, Martha Glenn, MD, David James Inwards, MD, Kay Ristow, Reem Karmali, MD MS, Jason Kaplan, MD, Elvira Umyarova, MD, Bhargavi Pulluri, MD, Jennifer E Amengual, MD, Jennifer Kimberly Lue, MD, Paolo Caimi, MD, Jonathon B Cohen, MDMS, Oscar Calzada, BS, Elizabeth Handorf, Jennifer Kelly Anderson, MD, Parv Chapani, Veronika Bachanova, MD PhD, Saurabh Rajguru, MD, Michael C Churnetski, BS, Catherine Diefenbach, Martin Bast, Alexandra E. Kovach, MD

Blood (2017) 130 (Supplement 1): 341.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.341.341

Published: 2017

Journal Articles

Tissue Is the Issue: Accuracy of PET Imaging to Detect Bone Marrow Clearance in Patients with Peripheral T-Cell Lymphoma

Anthony Q Pham, MD, Stephen Broski, Thomas M. Habermann, MD, Dragan Jevremovic, MDPhD, Gregory Wiseman, MD, Andrew L Feldman, MD, Matthew J Maurer, MS, Kay Ristow, Thomas E. Witzig, MD

Blood (2015) 126 (23): 3947.

DOI: https://doi.org/10.1182/blood.V126.23.3947.3947

Published: 2015

Journal Articles

Lymphocyte-to-Monocyte Ratio at Diagnosis and Survival in De Novo Double/Triple Hit Diffuse Large B-Cell Lymphoma

Luis Porrata, MD, Kay Ristow, Ellen D. McPhail, MD, William Macon, MD, Matthew J Maurer, MS, Grzegorz S. Nowakowski, MD, Stephen Ansell, MD PhD, Thomas E. Witzig, MD, Svetomir Markovic, MD PhD, Thomas M. Habermann, MD

Blood (2015) 126 (23): 3885.

DOI: https://doi.org/10.1182/blood.V126.23.3885.3885

Published: 2015

Journal Articles

GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features

Tianjiao Wang, Andrew L. Feldman, David A. Wada, Ye Lu, Avery Polk, Robert Briski, Kay Ristow, Thomas M. Habermann, Dafydd Thomas, Steven C. Ziesmer, Linda E. Wellik, Thomas M. Lanigan, Thomas E. Witzig, Mark R. Pittelkow, Nathanael G. Bailey, Alexandra C. Hristov, Megan S. Lim, Stephen M. Ansell, Ryan A. Wilcox

Blood (2014) 123 (19): 3007–3015.

DOI: https://doi.org/10.1182/blood-2013-12-544809

Published: 2014

Includes: Supplemental data

Journal Articles

Long Term Clinical Outcomes in Patients with Massive Splenomegaly and Non-Hodgkin's Lymphoma Treated with Splenectomy.

Jacob Smeltzer, MD, Thomas M Habermann, MD, Taner Timucin, MD, PhD, David Nagorney, MD, Kay Ristow, Joseph P Colgan, MD, Thomas E. Witzig, MD, William Harmsen, Seth Slettedahl, John Donohue

Blood (2012) 120 (21): 2692.

DOI: https://doi.org/10.1182/blood.V120.21.2692.2692

Published: 2012

Journal Articles

The Absolute Monocyte and Lymphocyte Counts at Diagnosis Predict Survival and Identify High-Risk Patients In Diffuse Large-B-Cell Lymphoma

Ryan A. Wilcox, MD, PhD, Kay Ristow, Thomas M. Habermann, MD, David James Inwards, MD, Ivana Micallef, MD, Patrick B Johnston, MD, PhD, Joseph Colgan, Grzegorz S. Nowakowski, MD, Thomas E. Witzig, MD, Stephen M. Ansell, MD, PhD, Svetomir Markovic, MD, PhD, Luis Porrata, MD

Blood (2010) 116 (21): 3088.

DOI: https://doi.org/10.1182/blood.V116.21.3088.3088

Published: 2010

Journal Articles

Outcomes In the Pre-Rituximab and Post-Rituximab Eras In Post-Transplantation Lymphoproliferative Disorders (PTLD) In Adult Solid Organ Transplant Recipients

Thomas M. Habermann, MD, Matthew J Maurer, Kay Ristow, William R. Macon, MD, Timothy S Larson, MD, Yogis Kudva, MD, Randall Walker, MD, Russell H Wiesner, MD, Brooks S Edwards, MD, Stephen M. Ansell, MD, PhD

Blood (2010) 116 (21): 2859.

DOI: https://doi.org/10.1182/blood.V116.21.2859.2859

Published: 2010

Journal Articles

GATA-3 or T-Bet Expression In PTCL-U Identify High-Risk Patients with Poor Outcomes and Distinct Clinical Characteristics Suggesting Their Derivation From Specific Subsets of T Helper Cells

Ryan A. Wilcox, MD, PhD, Andrew L Feldman, MD, Kay Ristow, Thomas M. Habermann, MD, Steven Ziesmer, Linda Wellik, Thomas E. Witzig, MD, Stephen M. Ansell, MD, PhD

Blood (2010) 116 (21): 4125.

DOI: https://doi.org/10.1182/blood.V116.21.4125.4125

Published: 2010

Journal Articles

Primary Pulmonary MALT Lymphoma: Clinical Characteristics and Treatment Outcomes – Single Institution Experience

Grzegorz S. Nowakowski, MD, Kay Ristow, Paul Kurtin, MD, Mark S Allen, Ivana N Micallef, MD, Joseph Colgan, David James Inwards, MD, Ellen McPhail, MD, Svetomir Markovic, MD, PhD, Stephen M. Ansell, MD, PhD, Luis Porrata, MD, Patrick B Johnston, MD, PhD, Carrie A Thompson, MD, Thomas E. Witzig, MD, Thomas M. Habermann, MD

Blood (2010) 116 (21): 4168.

DOI: https://doi.org/10.1182/blood.V116.21.4168.4168

Published: 2010

Journal Articles

MYC Translocations Are Associated with Poor Overall Survival in DLBCL Patients in Both the Chemotherapy and Immunochemotherapy Eras.

Ahmet Dogan, MD, PhD, Matthew J Maurer, MS, William R Macon, MD, David J Inwards, MD, Ivana N Micallef, MD, Patrick L Johnston, MD, PhD, Mark Law, Kay Ristow, Thomas E Witzig, MD, James R Cerhan, MD, PhD, Thomas M Habermann, MD

Blood (2009) 114 (22): 443.

DOI: https://doi.org/10.1182/blood.V114.22.443.443

Published: 2009

Journal Articles

Absolute Lymphocyte Count at the Time of Relapse Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma.

Luis F. Porrata, MD, Kay Ristow, Thomas M Haberman, MD, Thomas E Witzig, MD, David James Inwards, MD, Stephen M Ansell, MD, PhD, Patrick B Johnston, MD, PhD, Ivana N. Micallef, MD, Joseph P Colgan, MD, William L White, MD, Svetomir N Markovic, MD, PhD

Blood (2008) 112 (11): 1763.

DOI: https://doi.org/10.1182/blood.V112.11.1763.1763

Published: 2008

Journal Articles

Primary Diffuse Large B-Cell Lymphoma of the Colon: Surgery for Local Disease Control Does Not Improve Outcome.

Rajini Katipamula, MBBS, Kay Ristow, Joseph P. Colgan, M.D., Thomas M. Habermann, M.D., Patrick B. Johnston, M.D., Ph.D, David J. Inwards, M.D., Svetomir N. Markovic, M.D., Ph.D, Ivana N. Micallef, M.D., Luis F. Porrata, M.D., William L. White, M.D., Thomas E. Witzig, M.D., Stephen M. Ansell, M.D., Ph.D

Blood (2007) 110 (11): 3444.

DOI: https://doi.org/10.1182/blood.V110.11.3444.3444

Published: 2007

Journal Articles

Absolute Lymphocyte Count Is Independent of the Anaplastic Lymphoma Kinase and Predicts Survival in Primary Anaplastic Large Cell Lymphoma.

Luis F. Porrata, MD, Kay Ristow, Thomas E. Witzig, MD, Thomas M. Haberman, MD, David J. Inwards, MD, Stephen M. Ansell, MD, PhD, Ivana N. Micallef, MD, Patrick B. Johnston, MD, PhD, Joseph Colgan, MD, William L. White, MD, Svetomir N. Markovic, MD, PhD

Blood (2007) 110 (11): 1335.

DOI: https://doi.org/10.1182/blood.V110.11.1335.1335

Published: 2007

Journal Articles

Improved Survival in Patients with Peripheral T Cell Lymphoma, Unspecified Following High-Dose Therapy and Stem Cell Transplantation: A Retrospective Review of a Single Institution’s Experience.

Ryan A. Wilcox, MD, PhD, Ahmet Dogan, MD, PhD, Kay Ristow, Joseph P. Colgan, MD, Thomas M. Habermann, MD, David J. Inwards, MD, Patrick B. Johnston, MD, PhD, Svetomir N. Markovic, MD, PhD, Ivana N. M. Micallef, MD, Luis F. Porrata, MD, Thomas E. Witzig, MD, Stephen M. Ansell, MD, PhD

Blood (2006) 108 (11): 3062.

DOI: https://doi.org/10.1182/blood.V108.11.3062.3062

Published: 2006

Journal Articles

Prognostic Factors and Survival of Patients with Primary Mediastinal Large B-Cell Lymphoma.

Grzegorz S. Nowakowski, MD, Prabhjot Kaur, MD, William R. Macon, MD, Thomas M. Habermann, MD, Kay Ristow, Stephen M. Ansell, MD, PhD, Thomas E. Witzig, MD, Svetomir N. Markovic, MD, PhD, Luis F. Porrata, MD, Ivana N. Micallef, MD, Patrick B. Johnston, MD, Joseph P. Colgan, MD, David J. Inwards, MD

Blood (2005) 106 (11): 4698.

DOI: https://doi.org/10.1182/blood.V106.11.4698.4698

Published: 2005

Journal Articles

Absolute Lymphocyte Count Recovery during Standard Chemotherapy Predicts Superior Survival and Is Independent of the Hasenclever Index for Hodgkin’s Disease.

Mustaqeem Siddiqui, MD, Luis F. Porata, MD, Kay Ristow, Thomas M. Habermann, MD, Joseph P. Colgan, MD, William L. White, MD, Thomas E. Witzig, MD, David J. Inwards, MD, Stephen M. Ansell, MD, PhD, Ivana N. Micallef, MD, Patrick B. Johnston, MD, PhD, William G. Martin, MD, James A. Martenson, MD, Scott L. Stafford, MD, Svetomir N. Markovic, MD, PhD

Blood (2005) 106 (11): 2667.

DOI: https://doi.org/10.1182/blood.V106.11.2667.2667

Published: 2005

NARROW

Consolidation with Autologous Hematopoietic Cell Transplant in First Remission Improves Overall Survival in Younger Patients with Mantle Cell Lymphoma in the Rituximab Era

Tissue Is the Issue: Accuracy of PET Imaging to Detect Bone Marrow Clearance in Patients with Peripheral T-Cell Lymphoma

Lymphocyte-to-Monocyte Ratio at Diagnosis and Survival in De Novo Double/Triple Hit Diffuse Large B-Cell Lymphoma

GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features

Long Term Clinical Outcomes in Patients with Massive Splenomegaly and Non-Hodgkin's Lymphoma Treated with Splenectomy.

The Absolute Monocyte and Lymphocyte Counts at Diagnosis Predict Survival and Identify High-Risk Patients In Diffuse Large-B-Cell Lymphoma

Outcomes In the Pre-Rituximab and Post-Rituximab Eras In Post-Transplantation Lymphoproliferative Disorders (PTLD) In Adult Solid Organ Transplant Recipients

GATA-3 or T-Bet Expression In PTCL-U Identify High-Risk Patients with Poor Outcomes and Distinct Clinical Characteristics Suggesting Their Derivation From Specific Subsets of T Helper Cells

Primary Pulmonary MALT Lymphoma: Clinical Characteristics and Treatment Outcomes – Single Institution Experience

MYC Translocations Are Associated with Poor Overall Survival in DLBCL Patients in Both the Chemotherapy and Immunochemotherapy Eras.

Absolute Lymphocyte Count at the Time of Relapse Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma.

Primary Diffuse Large B-Cell Lymphoma of the Colon: Surgery for Local Disease Control Does Not Improve Outcome.

Absolute Lymphocyte Count Is Independent of the Anaplastic Lymphoma Kinase and Predicts Survival in Primary Anaplastic Large Cell Lymphoma.

Improved Survival in Patients with Peripheral T Cell Lymphoma, Unspecified Following High-Dose Therapy and Stem Cell Transplantation: A Retrospective Review of a Single Institution’s Experience.

Prognostic Factors and Survival of Patients with Primary Mediastinal Large B-Cell Lymphoma.

Absolute Lymphocyte Count Recovery during Standard Chemotherapy Predicts Superior Survival and Is Independent of the Hasenclever Index for Hodgkin’s Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only